Nicolas de Tribolet

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia et al. · New England Journal of Medicine · 2005 · 7.3K citations · Full text

Medicine, Molecular Biology, Oncology +17

HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity

Virginie Clément, Pilar Sánchez‐Gómez, Nicolas de Tribolet et al. · Current Biology · 2006 · 1K citations · Full text

Medicine, Cancer Biology, Oncology +12

Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide

Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic et al. · Journal of Clinical Oncology · 2002 · 815 citations

Medicine, Oncology, Radiation Oncology +17

Clinical Trial Substantiates the Predictive Value of <b> <i>O-6-Methylguanine-DNA Methyltransferase</i> </b> Promoter Methylation in Glioblastoma Patients Treated with Temozolomide

Monika E. Hegi, Annie-Claire Diserens, Sophie Godard et al. · Clinical Cancer Research · 2004 · 791 citations

Medicine, Molecular Genetics, Radiation Oncology +17

Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia et al. · Journal of Clinical Oncology · 2008 · 735 citations · Full text

Medicine, Cancer Biology, Oncology +17